Eurosurveillance banner



In this issue


Home Eurosurveillance Weekly Release  2005: Volume 10/ Issue 28 Article 4 Printer friendly version
Back to Table of Contents
Previous Next

Eurosurveillance, Volume 10, Issue 28, 14 July 2005
Articles

Citation style for this article: Liassine N, Caulfield A, Ory G, Restellini A, de Barbeyrac B, Sitavanc R, Descombes MC, Luescher D. First confirmed case of lymphogranuloma venereum (LGV) in Switzerland. Euro Surveill. 2005;10(28):pii=2748. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2748

First confirmed case of lymphogranuloma venereum (LGV) in Switzerland

Nadia Liassine1 (nliassine@unilabs.ch), Aileen Caulfield2, Gaelle Ory3, Alexandre Restellini3, Bertille de Barbeyrac4, Radan Sitavanc1, Marie-Christine Descombes1 and Dieter Luescher5

1Bioanalytique-Riotton, Unilabs group, Geneva, Switzerland
2Centre Médical du Léman, Geneva, Switzerland
3Groupe Médical d’Onex, Geneva, Switzerland
4Centre National de Référence des Chlamydia, Université de Bordeaux 2, France
5Diagnostica, Unilabs group, Zürich, Switzerland

In April 2005, a 31 year old man in Geneva presented with anorectal syndrome (rectal pain and bloody stools) and diarrhoea which had been occurring at least 3-4 times per day for 2 weeks. He reported having unprotected anal intercourse with a man in Berlin approximately 6 weeks prior to symptom onset. Endoscopic examination of the colon revealed inflammation of the distal third of the rectum with areas of small superficial erosions and one large erosion covered with fibrin.

Microbiological analysis of a rectal biopsy using polymerase chain reaction (PCR) showed the presence of Chlamydia trachomatis. A molecular technique confirmed the case as L2 genotype [1]. High titres of C. trachomatis IgG (1280) and IgA (160) were observed using immunofluorescence assay. Tests for syphilis, HIV, and gonorrhea were all negative. The patient was treated with doxycyline 100mg twice daily for three weeks. After this, symptoms were had decreased but not resolved, and so he was given a second antibiotic treatment of erythromycin 500mg four times daily for three weeks. The patient improved after this treatment. Proctoscopic examination was repeated 3 weeks after the end of treatment and showed normal macroscopic rectal mucosa. Repeat PCR in a rectal specimen also showed the absence of C. trachomatis at this stage.

This is the first confirmed case of lymphogranuloma venereum (LGV) in Switzerland [2]. Two previously suspected cases (PCR of C. trachomatis positive in rectal specimens) were diagnosed in Geneva in February and April 2004. The lack of diagnostic facilities in Switzerland prevented an adequate diagnosis. Recently, an increase of sexually transmitted infections (STI), particularly syphilis and Neisseria gonorrhoeae infections, has been reported in Switzerland, especially in Geneva and Zürich [3]. LGV’s emergence in Switzerland following the reports of LGV in men who have sex with men (MSM) in different European cities is not surprising. LGV is probably underdiagnosed in Switzerland at present.

Outbreaks of LGV in MSM have been reported since 2004 in Europe [4,5] and the United States and Canada [6,7]. It is crucial to inform medical workers and high risk populations of this new STI so that patients can be treated rapidly and appropriately, and dissemination of the disease avoided [12]. Enhanced surveillance programmes are now being implemented in France, the United Kingdom and the Netherlands [1,5,8]. Diagnostic tests specific for LGV are urgently needed.

References:
  1. Herida M, Sednaoui P, Couturier E, Neau D, Clerc M, Scieux C, et al. Rectal lymphogranuloma venereum, France [letter]. Emerg Infect Dis 2005; 11(3)505-6. (http://www.cdc.gov/ncidod/EID/vol11no03/04-0621.htm)
  2. Premier cas de lymphogranulomatose vénérienne dans le canton de Genève. Bulletin BAG 2005;(25):432-3. (http://www.bag.admin.ch/dienste/publika/bulletin/f/BU25_05f.pdf)
  3. Lautenschlager S. Sexually transmitted infections in Switzerland : return of the classics. Dermatology 2005; 210: 134-42.
  4. Götz H, Nieuwenhuis R, Ossewaarde T, Bing Thio H, van der Meijden M, Dees J, et al. Preliminary report of an outbreak of lymphogranuloma venereum in homosexual men in the Netherlands, with implications for other countries in western Europe. Eurosurveillance Weekly 2004; 8(4): 22/01/2004 (http://www.eurosurveillance.org/ew/2004/040122.asp#1)
  5. Van de Laar MJ, Fenton KA, Ison C. Update on the European lymphogranuloma venereum epidemic among men who have sex with men. Eurosurveillance Weekly 2005; 10(22): 02/06/2005. (http://www.eurosurveillance.org/ew/2005/050602.asp)
  6. PRO/EDR> Lymphogranuloma venereum - USA (New York City). in: ProMED-mail [online]. Boston US: International Society for Infectious Diseases, archive number 20050203.0369, 3 February 2005. (http://www.promedmail.org)
  7. Kropp RY, Wong T; Canadian LGV Working Group. Emergence of lymphogranuloma venereum in Canada. CMAJ 2005; 172(13) :1674-6. Epub 2005 May 31. (http://www.cmaj.ca/cgi/content/full/172/13/1674)
  8. French P, Ison CA, Macdonald N. Lymphogranuloma venereum in the United Kingdom. Sex Transm Infect 2005; 81(2):97-8.

back to top



Back to Table of Contents
Previous Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.